1)日本透析医学会統計調査委員会:図説 わが国の慢性透析療法の現況―2009年12月31日現在.日本透析医学会,東京,2010
2)土田健司,武本佳昭,吉村力勇,他:HDFに期待するもの―HDFの経済効果.腎と透析 57(別冊HDF療法'04):29-31,2004
3)日本透析医学会統計調査委員会:わが国の慢性透析療法の現況―2008年12月31日現在.透析会誌 43:1-35,2009
4)小野信行,田邊恵子,原 賢策,他:内部濾過促進型ダイアライザーAPS-21EXの性能評価.腎と透析 59(別冊HDF療法'05):194-197,2005
5)Tsuchida K, Takemoto Y, Yamagami S, et al:Detection of peptidoglycan and endotoxin in dialysate using silkworm larvae plasma and limulus amebocyte lysate methods. Nephron 75:438-443, 1997
6)Ledebo I:Purification of dialysis fluid:historical background and perspective. Blood Purif 27(Suppl 1):17-19. 2009
7)秋葉 隆,川西秀樹,峰島三千男,他:透析液水質基準と血液浄化器性能評価基準2008.透析会誌 41:159-167,2008
8)Nakatani T, Tsuchida K, Sugimura K, et al:Investigation of endotoxin adsorption with polyether polymer alloy dialysis membranes. Int J Mol Med 11:195-197, 2003
study. Artificial Organs 28:231-234, 2004
10)Nakatani T, Tsuchida K, Sugimura K, et al:Response of peripheral blood mononuclear cells in hemodialyzed patients against andotoxin and muramyldipeptide. Int J Mol Med 10:469-472, 2002
11)Kuroki Y, Tsuchida K, Go I, et al:A study of innate immunity in patients with end-stage renal disease:special reference to toll-like receptor-2 and-4 expression in peripheral blood monocytes of hemodialysis patients. Int J Mol Med 19:783-790, 2007
12)Schindler R, Beck W, Deppisch R, et al:Short bacterial DNA fragments:detection in dialysate and induction of cytokines. J Am Soc Nephrol 15:3207-3214, 2004
13)Baz M, Durand C, Ragon A, et al:Using ultrapure water in hemodialysis delays carpal tunnel syndrome. Int J Artif Organs 14:681-685, 1991
14)Go I, Takemoto Y, Tsuchida K, et al:The effect of ultrapure dialysate on improving renal anemia. Osaka City Med J 53:17-23, 2007
15)Lederer SR and Schiffl H:Ultrapure dialysis fluid lowers the cardiovascular morbidity in patients on maintenance hemodialysis by reducing continuous microinflammation. Nephron 91:452-455, 2002
16)Schiffl H, Lang SM, Stratakis D, et al:Effects of ultrapure dialysis fluid on nutritional status and inflammatory parameters. Nephrol Dial Transplant 16:1863-1869, 2001
17)Schiffl H, Lang SM and Fischer R:Ultrapure dialysis fluid slows loss of residual renal function in new dialysis patients. Nephrol Dial Transplant 17:1814-1818, 2002
18)Abel JJ, Rowntree LG and Turner BB:On the removal of diffusible substances from the circulating blood of living animals by dialysis. J Pharmacol Exp Ther 5:275-316, 1914
19)Kolff WJ, Berk HTJ, Welle M, et al:The artifical kidney:a dialyser with a great area. Acta Med Scand 117:121-134, 1944
20)前田貞亮,池田隆夫,小高通夫,他:透析液の組成について.人工透析研究会誌 1:5-18,1968
21)Mion CM, Hegstrom RM, Scribner BH, et al:Substitution of sodium acetate for sodium bicarbonate in the bath fluid for hemodialysis. Trans Amer Soc Artif Int Organs 10:110-113, 1964
22)山川 眞:アセテート.臨牀透析 2:60-616,1986
human interleukin-1 production by sodium acetate. Lancet I 8523:14-16, 1987
24)Canaud B:Effect of online hemodiafiltration on morbidity and mortality of chronic kidney disease patients. Contrib Nephrol 158:216-224, 2007
25)久野 勉,友 雅司,青池郁夫:「酢酸フリー」透析剤 カーボスターRのもたらす臨床効果と課題.Pharma Medica 26:63-68,2008
26)Vanholder R, De Smet R, Glorieux G, et al;European Uremic Toxin Work Group(EUTox):Review on uremic toxins:classification, concentration, and interindividual variability. Kidney Int 63:1934-1943, 2003
27)川西秀樹:HDF療法の生命予後への効果.腎と透析 51(別冊HDF療法'01):11-13,2001
28)Muñoz R, Gallardo I, Valladares E, et al:Online hemodiafiltration:4 years of clinical experience. Hemodial Int 10(Suppl 1):S28-32, 2006
29)Panichi V, Rizza GM, Paoletti S, et al;RISCAVID Study Group:Chronic inflammation and mortality in haemodialysis:effect of different renal replacement therapies. Results from the RISCAVID study. Nephrol Dial Transplant 23:2337-2343, 2008(Epub 2008 Feb 27)
30)Canaud B, Chenine L, Henriet D, et al:Online hemodiafiltration:a multipurpose therapy for improving quality of renal replacement therapy. Contrib Nephrol 161:191-198, 2008